TCMBANKIN021251 |
2,6-dimethoxy-4-hydroxy-1-O-β-D- glucopyranoside |
|
|
|
|
TCMBANKIN023698 |
(5S,6S)-5-isopropenyl-3,6-dimethyl-6-vinyl-5,7-dihydrobenzofuran-4-one |
(5S,6S)-6-ethenyl-3,6-dimethyl-5-prop-1-en-2-yl-5,7-dihydro-1-benzofuran-4-one |
C15H18O2 |
230.3 |
|
TCMBANKIN029959 |
5,6-dehydrosarmentogenin 3-O-β-D-glucopyranosyl(1→6)-O-β-D-galactopyranoside |
|
|
|
|
TCMBANKIN032180 |
5-o-methylvisamminol |
(2S)-2-(1-hydroxy-1-methyl-ethyl)-4-methoxy-7-methyl-2,3-dihydrofuro[3,2-g]chromen-5-one; (2S)-2-(2-hydroxypropan-2-yl)-4-methoxy-7-methyl-2,3-dihydrofuro[3,2-g]chromen-5-one; SCHEMBL4740689; DTXSID10331695; LMPK02000028; C09016; 5H-Furo[3,2-g][1]benzopyran-5-one,2,3-dihydro-2-(1-hydroxy-1-methylethyl)-4-methoxy-7-methyl-, (2S)-; (2S)-2-(1-hydroxy-1-methylethyl)-4-methoxy-7-methyl-2,3-dihydrofuro[3,2-g]chromen-5-one; 80681-42-1; ZINC4097844; LMPK13110002; CHEBI:2110; 5-O-Methylvisamminol; AC1L9C12 |
C16H18O5 |
290.31 g/mol |
CC1=CC(=O)C2=C(C3=C(C=C2O1)OC(C3)C(C)(C)O)OC |
TCMBANKIN033860 |
(3s)-methoxy-1,7-bis(4-hydroxyphenyl)-6 e-hepten-5-one |
|
C20H22O4 |
|
COC(CCC1=CC=C(C=C1)O)CC(=O)C=CC2=CC=C(C=C2)O |
TCMBANKIN037149 |
Blepharocalyxin E |
|
|
879 g/mol |
|
TCMBANKIN038339 |
Helichrysetin |
|
|
286.28 g/mol |
|
TCMBANKIN039619 |
Calyxin I |
|
|
686.7 g/mol |
|
TCMBANKIN040141 |
Blepharocalyxin D |
|
|
592.7 g/mol |
|
TCMBANKIN040208 |
4,4′-Dihydroxychalcone |
|
|
|
|
TCMBANKIN041033 |
epicalyxin k |
|
C35H34O8 |
582.6 g/mol |
COC1=C2C(=O)CC(OC2=C(C(=C1)O)C3CC(OC(C3)C4=CC=C(C=C4)O)CCC5=CC=C(C=C5)O)C6=CC=C(C=C6)O |
TCMBANKIN041780 |
trans-Methyl p-coumarate |
|
|
|
|
TCMBANKIN042975 |
Epicalyxin J |
|
|
686.7 g/mol |
|
TCMBANKIN043270 |
p-Coumaric acid |
CHEBI:32373; Para-Coumaric acid; ZB001183; trans-4-Hydroxycinnamic acid; (E)-3-(4-Hydroxyphenyl)-2-propenoic acid; 2-propenoic acid, 3-(4-hydroxyphenyl)-, (2E)-; Naringeninic acid; p-Cumaric acid; CHEBI:36090; p-Coumaric acid,trans; 501-98-4; (E)-3-(4-hydroxyphenyl)acrylic acid; trans-4-coumarate; 4'-Hydroxycinnamic acid; 4-(2-Carboxyethenyl)phenolate; HC4; trans-4-hydroxycinnamate; trans-p-Coumarinic acid; 4-hydroxycinnamate anion; 3-(4-hydroxyphenyl)acrylic acid; (2E)-3-(4-hydroxyphenyl)prop-2-enoic acid; 3-(4-hydroxyphenyl)prop-2-enoate; trans-p-Hydroxycinnamic acid; (E)-3-(4-hydroxyphenyl)prop-2-enoate; (E)-p-Hydroxycinnamic acid; 3-(4-hydroxyphenyl)acrylate; trans-4-coumaric acid; trans-p-Coumaric acid; (2E)-3-(4-hydroxyphenyl)acrylate; 4-10-00-01005 (Beilstein Handbook Reference); C00811; (2E)-3-(4-hydroxyphenyl)acrylic acid; BRN 2207383; CHEBI:12876; beta-(4-Hydroxyphenyl)acrylic acid; Para coumaric acid; COUMARATE; MLS001066419; 28200_FLUKA; p-Hydroxyphenylacrylic acid; Cinnamic acid, p-hydroxy-; 4-Coumaric acid; InChI=1/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12; 7400-08-0; beta-[4-hydroxyphenyl]acrylic acid; A828008; p-coumaricacid; SBB007613; 4-Hydroxycinnamate; Cinnamic acid, p-hydroxy-, (E)-; SMR000112201; 0-10-00-00297 (Beilstein Handbook Reference); CINNAMIC ACID,4-HYDROXY P-COUMARIC ACID; (E)-p-Coumaric acid; AIDS027710; CJ-00262; (2E)-3-(4-hydroxyphenyl)prop-2-enoate; 2-Propenoic acid, 3-(4-hydroxyphenyl)-; ZINC00039811; .beta.-[4-Hydroxyphenyl]acrylic acid; p-coumaric acid ; AC1NRBN2; InChI=1/C9H8O3/c10-8-4-1-7(2-5-8)3-6-9(11)12/h1-6,10H,(H,11,12)/b6-3; trans-p-coumarate; (E)-3-(4-hydroxyphenyl)prop-2-enoic acid; 4-Oxylatocinnamate; p-Hydroxycinnamic acid; HYDROXYCINNAMIC ACID; EINECS 231-000-0; BRN 2207381; NSC 674321; Enamine_005378; 4-Hydroxycinnamic acid; CHEBI:32374; NSC674321; AIDS-027710; 2-Propenoic acid, 3-(4-hydroxyphenyl)-, (E)- (9CI); NSC59260; p-coumarate; (E)-3-(4-hydroxyphenyl)-2-propenoate; C9008_SIGMA; 3-(4-Hydroxyphenyl)-2-propenoic acid; 3-(4-hydroxyphenyl)prop-2-enoic acid; 4-coumarate; NSC 59260 |
C9H8O3 |
164.158 |
c1([H])c([H])c(O[H])c([H])c([H])c1\C([H])=C([H])\C(=O)O[H] |
TCMBANKIN043283 |
epicalyxin i |
|
C42H38O9 |
686.7 g/mol |
COC1=C(C2=C(C3CC(OC(C3C(O2)C4=CC=C(C=C4)O)C5=CC=C(C=C5)O)CCC6=CC=C(C=C6)O)C(=C1)O)C(=O)C=CC7=CC=C(C=C7)O |
TCMBANKIN043832 |
p-hydroxybenzaldehyde |
p-hydroxybenz-aldehyde; 298704-22-0; p- hydroxybenzaldehyde; SCHEMBL13804892; p-hydroxy benzaldehyde; 4-hydroxy-[2,3,5,6,7-2H5]-benzaldehyde; p-hydroxy-benzaldehyde; p-HBAld |
C7H6O2 |
127.15 g/mol |
C1=CC(=CC=C1C=O)O |
TCMBANKIN044987 |
Calyxin K |
|
|
582.6 g/mol |
|
TCMBANKIN045148 |
Calyxin A |
|
|
582.6 g/mol |
|
TCMBANKIN045302 |
Epicalyxin M |
|
|
|
|
TCMBANKIN046338 |
calyxin m |
|
C35H34O8 |
582.6 g/mol |
COC1=C2C(=O)CC(OC2=C3C(CC(OC3=C1)C4=CC=C(C=C4)O)CC(CCC5=CC=C(C=C5)O)O)C6=CC=C(C=C6)O |
TCMBANKIN046663 |
Calyxin L |
|
|
582.6 g/mol |
|
TCMBANKIN046818 |
deoxycalyxin a |
|
C35H34O7 |
566.6 g/mol |
COC1=C(C(=C(C(=C1)O)C(CCCCC2=CC=C(C=C2)O)C=CC3=CC=C(C=C3)O)O)C(=O)C=CC4=CC=C(C=C4)O |
TCMBANKIN047029 |
calyxin e |
|
C35H34O8 |
582.6 g/mol |
COC1=C2C(=O)CC(OC2=C(C(=C1)O)C(CC(CCC3=CC=C(C=C3)O)O)C=CC4=CC=C(C=C4)O)C5=CC=C(C=C5)O |
TCMBANKIN049373 |
blepharocalyxin c |
|
C38H42O7 |
610.7 g/mol |
C1C(OC(C(C1O)C(CC(CCC2=CC=C(C=C2)O)O)C=CC3=CC=C(C=C3)O)C4=CC=C(C=C4)O)CCC5=CC=C(C=C5)O |
TCMBANKIN049516 |
Neocalyxin A |
|
|
474.5 g/mol |
|
TCMBANKIN050110 |
calyxin g |
|
C35H34O8 |
582.6 g/mol |
COC1=C2C(=O)CC(OC2=C(C(=C1)O)C3CC(OC(C3)C4=CC=C(C=C4)O)CCC5=CC=C(C=C5)O)C6=CC=C(C=C6)O |
TCMBANKIN050248 |
Calyxin J |
|
|
686.7 g/mol |
|
TCMBANKIN058081 |
Dilospan S |
1,3,5-Benzenetriol; P1178_SIGMA; ST5214381; 5-Benzenetriol; 79330_FLUKA; Floroglucinol [Czech]; CHEBI:16204; 108-73-6; c0026; 1,3,5-THB; NSC 1572; D00152; Phloroglucinol solution; Benzene-s-triol; WLN: QR CQ EQ; InChI=1/C6H6O3/c7-4-1-5(8)3-6(9)2-4/h1-3,7-9; 3,5-Dihydroxyphenol; s-Trihydroxybenzene; C02183; sym-Trihydroxybenzene; CPD-16; 1,3,5-Trihydroxycyclohexatriene; AIDS017800; AIDS-017800; Phloroglucinol (JAN); ZINC00391883; Benzene, trihydroxy; BRN 1341907; P38005_ALDRICH; Benzene, 1,3,5-trihydroxy-; 1,3,5-Triol; NCGC00166270-01; Benzene-1,3,5-triol; Phloroglucine; Spasfon-Lyoc; Floroglucin [Czech]; EINECS 203-611-2; Phloroglucinol; 34611_RIEDEL; 5-Hydroxyresorcinol; 4-06-00-07361 (Beilstein Handbook Reference); NSC1572; 5-Oxyresorcinol; P3502_SIAL; AI3-08848; Dilospan S (TN); CCRIS 4147; Phloroglucin; 1,3,5-Trihydroxybenzene; 5-Oxyresorcinolphloroglucin; phloroglucinol |
C6H6O3 |
126.11 |
C1=C(C=C(C=C1O)O)O |
TCMBANKIN058245 |
1,7-double-(4-Hydroxyphenyl)-4,6-Heptadiene-3-ketone |
1,7-bis (4-hydroxyphenyl)-4,6- heptabien-3-one; 1,2-dihydrobis(de-o-methyl)-curcumin |
C19H18O4 |
|
C1=CC(=CC=C1CCC(=O)C=C(C=CC2=CC=C(C=C2)O)O)O |
TCMBANKIN058246 |
1,7-bis(4-一hydroxyphenyl)-hepta-4E,6E-dien-3-one;1,7-bis(4-hydroxyphenyl)hepta-4e,6 e-dien-3-one;(4E,6E)-1,7-bis(4-hydroxyphenyl)hepta-4,6-dien-3-one |
|
C19H18O3 |
294.3 g/mol |
C1=CC(=CC=C1CCC(=O)C=CC=CC2=CC=C(C=C2)O)O |
TCMBANKIN058251 |
(3s,5s)-3,5-dihydroxy-1,7-bis(4-hydroxyphenyl)heptane |
hannokinol |
C19H24O4 |
|
C1=CC(=CC=C1CCC(CC(CCC2=CC=C(C=C2)O)O)O)O |
TCMBANKIN058533 |
(3s,5r,6s,7r)-5,6-dihydroxy-1,7-bis(4-hydroxy-phenyl)-de-o-methylcentrolobine;(3s,5s,6r,7r)-5,6-dihydroxy-1,7-bis(4-hydroxy-phenyl)-de-o-methylcentrolobine;(3s,5s,6s,7r)-5,6-dihydroxy-1,7-bis(4-hydroxy-phenyl)-4 ′′-de-o-methylcentrolobine |
|
C19H22O5 |
|
C1C(OC(C(C1O)O)C2=CC=C(C=C2)O)CCC3=CC=C(C=C3)O |
TCMBANKIN058552 |
(3s,7s)-5,6-dehydro-4 ′′-de-o-methylcentro-lobine |
(3s,7r)-5,6-dehydro-1,7-bis(4-hydroxyphenyl)-4′′-de-o-methylcentrolobine |
C19H20O3 |
|
C1C=CC(OC1CCC2=CC=C(C=C2)O)C3=CC=C(C=C3)O |
TCMBANKIN058917 |
p-Hydroxybenzalacetone |
methyl p-hydroxycinnamoyl ketone; 22214-30-8; ZINC00301268; EINECS 221-607-9; 1-(4-Hydroxybenzylidene)acetone; 4-Hydroxybenzal acetone; AI3-35956; 4-(p-Hydroxyphenyl)-3-buten-2-one; p-Hydroxybenzylidene acetone; (E)-4-(4-hydroxyphenyl)but-3-en-2-one; 4-Hydroxycinnamoylmethane; NSC26516; C12088; 3-Buten-2-one, 4-(p-hydroxyphenyl)-; 3-Buten-2-one, 4-(4-hydroxyphenyl)-; ST5409297; AIDS017763; AIDS-017763; AI3-30539; 3-Buten-2-one, 4-(4-hydroxyphenyl)-, (E)-; 3160-35-8; 4-(4-Hydroxyphenyl)but-3-en-2-one; NSC 26516 |
C10H10O2 |
162.19 |
CC(=O)C=CC1=CC=C(C=C1)O |
TCMBANKIN060448 |
4-hydroxy-5-methoxy-10-methyl-oxecane-2,7-dione a |
|
C11H18O5 |
|
CC1CCC(=O)CC(C(CC(=O)O1)O)OC |
TCMBANKIN061268 |
(3s,5s)-3-hydroxy-5-ethoxy-1-(4-hydroxy-phenyl)-7-phenyl-6 e-heptene |
|
C21H26O3 |
|
CCOC(CC(CCC1=CC=C(C=C1)O)O)C=CC2=CC=CC=C2 |
TCMBANKIN061428 |
(3s,5s)-3-hydroxy-5-methoxy-1-(4-hydroxy-phenyl)-7-phenyl-6 e-heptene |
(3s,5r)-3-hydroxy-5-methoxy-1-(4-hydroxy-phenyl)-7-phenyl-6 e-heptene |
C20H24O3 |
|
COC(CC(CCC1=CC=C(C=C1)O)O)C=CC2=CC=CC=C2 |
TCMBANKIN061431 |
epicalyxin f |
calyxin f |
C35H34O8 |
582.6 g/mol |
COC1=C(C(=C(C(=C1)O)C2CC(OC(C2)C3=CC=C(C=C3)O)CCC4=CC=C(C=C4)O)O)C(=O)C=CC5=CC=C(C=C5)O |
TCMBANKIN061693 |
neocalyxin a |
neocalyxin b |
C28H26O7 |
474.5 g/mol |
COC1=C2C(=O)CC(OC2=C3C4CC(OC4OC3=C1)CCC5=CC=C(C=C5)O)C6=CC=C(C=C6)O |